Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma

Journal of Bone and Joint Surgery

Volumn 80, Issue 1, 1998, Pages 11-17

  Berend, Keith R ^a,b   Toth, Alison P ^a,b   Harrelson, John M ^a,b   Layfield, Lester J ^a,b   Hey, Lloyd A ^a,b   Scully, Sean P ^a,b  

^a Duke University Medical Center ^*

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COMPLEMENTARY DNA; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CHONDROSARCOMA; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TUMOR LOCALIZATION;

EID: 0031909615     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199801000-00004     Document Type: Article

References (18)

1. Alessandro, R.; Minafra, S.; Pucci-Minafra, I.; Onisto, M.; Garbisa, S.; Melchiori, A.; Tetlow, L.; and Woolley, D. E.: Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Internat. J. Cancer, 55: 250-255,1993.
2. Berend, K. R.; Toth, A. P.; Block, J. A.; and Scully, S. P.: MMP and TIMP expression correlates with level of differentiation and the resorptive phenotype in human chondrosarcoma. Unpublished data.
3. Block, J. A.; Qureshi, A.; and Gitelis, S.: Chondrosarcoma. Curr. Opin. Orthop., 5(5): 70-74, 1994.
4. De Clerck, Y. A., and Imren, S.: Protease inhibitors: role and potential therapeutic use in human cancer. European J. Cancer, 30A: 2170-2180, 1994.
5. De Clerck, Y. A.; Shimada, H.; Taylor, S. M.; and Langley, K. E.: Matrix metalloproteinases and their inhibitors in tumor progression. Ann. New York Acad. Sci., 732: 222-232, 1994.
6. De Clerck, Y. A.; Alvarez, O.; Shimada, H.; Taylor, S. M.; and Langley, K. E.: Tissue inhibitors of metalloproteinases: role in tumor progression. Contrib. Nephrol., 107: 108-115, 1994.
7. Hasegawa, T.; Seki, K.; Yang, P.; Hirose, T.; Hizawa, K.; Wada, T.; and Wakabayashi, J.: Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum. Pathol., 26: 838-845, 1995.
8. Kohn, E. C.: Development and prevention of metastasis. Anticancer Res., 13: 2553-2590, 1993.
9. Lewis, M. M.; Sissons, H. A.; Norman, A.; and Greenspan, A.: Benign and malignant cartilage tumors. In Instructional Course Lectures, The American Academy of Orthopaedic Surgeons. Vol. 36, pp. 87-114. Park Ridge, Illinois, The American Academy of Orthopaedic Surgeons, 1987.
10. Matrisian, L. M.: Matrix metalloproteinase gene expression. Ann. New York Acad. Sci., 732: 42-50, 1994.
11. Murphy, G., and Docherty, A. J.: The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell and Molec. Biol., 7: 120-125, 1992.
12. Nawa, G.; Ueda, T.; Mori, S.; Yoshikawa, H.; Fukuda, H.; Ishiguro, S.; Funai, H.; and Uchida, A.: Prognostic significance of Ki67 (MIB1) proliferation index and p53 over-expression in chondrosarcomas. Internal. J. Cancer, 69: 86-91, 1996.
13. Nuovo, G. J.; MacConnell, P. B.; Simsir, A.; Valea, F.; and French, D. L.: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res., 55: 267-275, 1995.
14. Onisto, M.; Garbisa, S.; Caenazzo, C.; Freda, M. P.; Di Francesco, C.; Nitti, D.; Liotta, L. A.; and Stetler-Stevenson, W. G.: Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion. Diag. Molec. Pathol., 2: 74-80, 1993.
15. Overall, C. M.: Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann. New York Acad. Sci., 732: 51-64, 1994.
16. Ray, J. M., and Stetler-Stevenson, W. G.: The role of matrix metalloproteinases and their inhibitors in tumour invasion, metastasis and angiogenesis. European Respir. J., 7: 2062-2072, 1994.
17. Springfield, D. S.: Staging systems for musculoskeletal neoplasia. In Instructional Course Lectures, The American Academy of Orthopaedic Surgeons. Vol. 43, pp. 537-542. Rosemont, Illinois, The American Academy of Orthopaedic Surgeons, 1987.
18. Woessner, J. F., Jr.: The family of matrix metalloproteinases. Ann. New York Acad. Sci., 732: 11-21, 1994.